We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NOVEN: GENERIC FENTANYL BLOCKED BY CITIZEN PETITIONS
NOVEN: GENERIC FENTANYL BLOCKED BY CITIZEN PETITIONS
January 7, 2005
A “suspicious” string of citizen petitions is deliberately blocking Noven Pharmaceuticals’ efforts to bring a generic version of Johnson & Johnson’s (J&J) Duragesic transdermal pain patch to market, Noven claimed in a recent FDA filing.